This contact info of Dr. Reddy’s regarding 2DG drug procurement is incorrect - FACTLY
Sai Krishna Muthyanolla
May 20, 2021
Drug Controller General of India (DGCI) has approved 2DG for emergency use as an adjunct therapy drug in moderate to severe COVID-19 patients. Following this on 17 May 2021, the Union Health & Defense ministers released the first batch of 2DG drug. It is in this regard a social media post advising people who are in need of the drug to reach out to Dr. Deepak Sapra (deepaksapra@drreddys.com) and Dr. Mallikarjun Rao (mallikarjunard@drreddys.com), is going viral. Through this article let’s fact-check the veracity of the post.
Claim: Contact details Dr. Reddy Labs for procuring 2DG drug.
Fact: Dr. Reddy’s through a tweet stated that these contact details regarding the procurement of 2DG are incorrect. Also, the tweet requested to contact 2DG@drreddys.com for all queries related to 2DG. Their tweet has also advised people to beware of agents selling spurious or illegal products in the name of 2DG. Hence the claim made in the post is FALSE.
In reply to a Twitter user’s query regarding the veracity of the same message, Dr. Reddy’s has categorically stated that the piece of information is incorrect, and the tweet requested people contact 2DG@drreddys.com for all queries related to 2DG.
Wish to bring to your attention that the WhatsApp forward you refer to is completely incorrect. Please refer to the correct contact info below. Request you to help us fight misinformation by re-sharing the correct contact info on Twitter and WhatsApp.https://t.co/50KLNTk4Xi
Further, the tweet shared some important information regarding the drug which is as follows.
Further, the tweet advised people to beware of agents selling spurious or illegal products in the name of 2DG. News articles that give a low down on the drug can be read here and here. With this, we can conclude that the contact info regarding the procurement of 2DG drug shared in the post is incorrect.
To sum it up, this contact info of Dr. Reddy’s regarding 2DG drug procurement is incorrect.